Read the First Edition of The Lens, a new magazine by LSI arrow-icon

Micro Interventional Devices | Michael Whitman, CEO

Micro Interventional Devices, Inc. (MID) is a development stage medical device company focusing on the design, manufacture and commercialization of disruptive technologies for use in percutaneous structural heart repair procedures.
Speakers
Michael Whitman
Michael Whitman
CEO, Micro Interventional Devices

Michael Whitman is the founder and CEO of Micro Interventional Devices, Inc. (MID). Michael has over 30 years of medical device experience at market leading firms including, Johnson and Johnson, Olympus, Synthes and Power Medical Interventions. He previously was the founder and CEO of Power Medical Interventions (NASDAQ; PMII), which was acquired by Covidien Ltd. in 2009. Prior to founding PMI, Michael served in numerous management positions at Johnson and Johnson during his 13-year tenure including Vice President of Sales, Director of Sales and Marketing, Product Development and Product Management. He is the named inventor on over 35 US and foreign patents. He received his A.B. in Business and Economics from Lafayette College and completed graduate work at Wharton, University of Michigan, Harvard Executive Education, and Rutgers University.

LSI USA ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

March 17-21, 2025 Waldorf Astoria, Monarch Beach | Dana Point, CA Register arrow